Pavel Majer - Concepedia

Author

Pavel Majer

Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry ORCID

Also Known As

Majer, P., Majer, Pavel, P Majer, P. MAJER, P. Majer, PAVEL MAJER, Pavel Majer

193

Publications

4.3K

Citations

H-Index

123

Concepts

All Affiliations

Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry Charles University Czech Academy of Sciences Czech Academy of Sciences, Institute of Molecular Genetics Guilford College

About

Pavel Majer is an author at Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	33	1.7K
2	Natural Sciences	20	30	1.2K
3	Engineering	5	5	446
4	Health Sciences	1	1	31
5	Public Health	1	1	42

Pavel Majer

Publications

Citations

H-Index

Page 1

	Year	Citations
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells Min Hee Oh, Im‐Hong Sun, Liang Zhao, Journal of Clinical Investigation ImmunologyImmunoeditingImmunotherapyCancer BiologyTumor Biology	2020	404
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer J.R. Mesters, Cyril Bařinka, Weixing Li, The EMBO Journal Glutamate Carboxypeptidase IiDrug TargetBiochemistryG Protein-coupled ReceptorMedicine	2006	289
A Safe and Efficient Method for Preparation of N,N'-Unsymmetrically Disubstituted Ureas Utilizing Triphosgene Pavel Majer, Ramnarayan S. Randad The Journal of Organic Chemistry Combinatorial ChemistryAltmetricsEngineeringEfficient MethodNatural Sciences	1994	205
Synthesis and Biological Evaluation of <scp>d</scp>-Amino Acid Oxidase Inhibitors Dana Ferraris, Bridget Duvall, Yao-Sen Ko, Journal of Medicinal Chemistry	2008	134
Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II Cyril Bařinka, Markéta Rinnová, Pavel Šácha, Journal of Neurochemistry	2002	130
Discovery of 6-Diazo-5-oxo-<scp>l</scp>-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma Rana Rais, Andrej Jančařík, Lukáš Tenora, Journal of Medicinal Chemistry Don UtilizationPharmacotherapyHigh-grade GliomasExperimental PharmacologyGlioma	2016	128
Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models Ghanashyam D. Ghadge, Barbara S. Slusher, Amos Bodner, Proceedings of the National Academy of Sciences	2003	119
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug Rana Rais, Kathryn M. Lemberg, Lukáš Tenora, Science Advances	2022	110
Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II: Discovery of an Orally Active GCP II Inhibitor Pavel Majer, Paul Jackson, Greg Delahanty, Journal of Medicinal Chemistry Molecular PainPharmacotherapyChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	2003	106
Structural Basis of Interactions between Human Glutamate Carboxypeptidase II and Its Substrate Analogs Cyril Bařinka, Klára Hlouchová, Miroslava Rovenská, Journal of Molecular Biology BiochemistryG Protein-coupled ReceptorNatural SciencesMolecular SubstrateMolecular Biology	2008	105

Page 1